|
|
|
|
I Zimanyi, E Buck, JJ Abramson, MM Mack and IN Pessah
Department of Veterinary Pharmacology and Toxicology, University of California, Davis 95616.
Junctional sarcoplasmic reticulum (SR) membranes isolated from rabbit skeletal muscle were pretreated with 0.1-500 microM ryanodine under equilibrium conditions optimal for receptor binding, followed by the removal of bound alkaloid by several washes in Ca(2+)- and ryanodine- free buffer. Pretreatment with > 100 nM ryanodine results in a concentration-dependent decrease in the Bmax of the high affinity sites and a complete loss of measurable low affinity binding sites that persist for > 48 hr. Quantitative analysis of residual ryanodine using three different methods demonstrates that the inhibition is not the result of residual ryanodine bound to its receptor. Ca2+ transport measurements made with antipyrylazo III show that actively loaded ryanodine-pretreated SR exhibits a persistent insensitivity to ryanodine- and daunomycin-induced Ca2+ release that is not seen with washed control vesicles. Lipid bilayer membranes fused with SR vesicles exhibit rapidly fluctuating single-channel events with a conductance of 468 pS in asymmetric CsCl solutions. Ryanodine (10 microM) produces a unidirectional transition to a slowly fluctuating half-conductance state that is not reversed by perfusion of the bilayer with Ca(2+)-free buffer and subsequent addition of dithiothreitol. However, dithiothreitol added in the ryanodine pretreatment medium offers marked protection against ryanodine-induced loss of binding sites and allows complete restoration of native gating behavior of single channels in bilayer lipid membrane. Using three different experimental approaches, the data demonstrate that the alkaloid at micromolar concentration persistently alters SR Ca2+ release channel function, perhaps by uncoupling four negatively cooperative binding sites. The oxidation of critical receptor thiols is implicated in the process.
This article has been cited by other articles:
![]() |
G. Cherednichenko, C. W. Ward, W. Feng, E. Cabrales, L. Michaelson, M. Samso, J. R. Lopez, P. D. Allen, and I. N. Pessah Enhanced Excitation-Coupled Calcium Entry in Myotubes Expressing Malignant Hyperthermia Mutation R163C Is Attenuated by Dantrolene Mol. Pharmacol., April 1, 2008; 73(4): 1203 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yang, E. Esteve, I. N. Pessah, T. F. Molinski, P. D. Allen, and J. R. Lopez Elevated resting [Ca2+]i in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1591 - C1598. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Ta, W. Feng, T. F. Molinski, and I. N. Pessah Hydroxylated Xestospongins Block Inositol-1,4,5-trisphosphate-Induced Ca2+ Release and Sensitize Ca2+-Induced Ca2+ Release Mediated by Ryanodine Receptors Mol. Pharmacol., February 1, 2006; 69(2): 532 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Hurne, J. J. O'Brien, D. Wingrove, G. Cherednichenko, P. D. Allen, K. G. Beam, and I. N. Pessah Ryanodine Receptor Type 1 (RyR1) Mutations C4958S and C4961S Reveal Excitation-coupled Calcium Entry (ECCE) Is Independent of Sarcoplasmic Reticulum Store Depletion J. Biol. Chem., November 4, 2005; 280(44): 36994 - 37004. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gao, A. A. Voss, I. N. Pessah, F. T. Lauer, T. M. Penning, and S. W. Burchiel Ryanodine Receptor-Mediated Rapid Increase in Intracellular Calcium Induced by 7,8-Benzo(a)Pyrene Quinone in Human and Murine Leukocytes Toxicol. Sci., October 1, 2005; 87(2): 419 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jordan, H. Jiang, H. Li, and J. X. DiMario Inhibition of ryanodine receptor 1 in fast skeletal muscle fibers induces a fast-to-slow muscle fiber type transition J. Cell Sci., December 1, 2004; 117(25): 6175 - 6183. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cherednichenko, A. M. Hurne, J. D. Fessenden, E. H. Lee, P. D. Allen, K. G. Beam, and I. N. Pessah Conformational activation of Ca2+ entry by depolarization of skeletal myotubes PNAS, November 2, 2004; 101(44): 15793 - 15798. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Hui, H. R. Besch Jr., and K. R. Bidasee Effects of Ryanoids on Spontaneous and Depolarization-Evoked Calcium Release Events in Frog Muscle Biophys. J., July 1, 2004; 87(1): 243 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shtifman, C. Paolini, J. R. Lopez, P. D. Allen, and F. Protasi Ca2+ influx through {alpha}1S DHPR may play a role in regulating Ca2+ release from RyR1 in skeletal muscle Am J Physiol Cell Physiol, January 1, 2004; 286(1): C73 - C78. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yang, T. A. Ta, I. N. Pessah, and P. D. Allen Functional Defects in Six Ryanodine Receptor Isoform-1 (RyR1) Mutations Associated with Malignant Hyperthermia and Their Impact on Skeletal Excitation-Contraction Coupling J. Biol. Chem., July 3, 2003; 278(28): 25722 - 25730. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fill and J. A. Copello Ryanodine Receptor Calcium Release Channels Physiol Rev, October 1, 2002; 82(4): 893 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Fessenden, L. Chen, Y. Wang, C. Paolini, C. Franzini-Armstrong, P. D. Allen, and I. N. Pessah Ryanodine receptor point mutant E4032A reveals an allosteric interaction with ryanodine PNAS, February 8, 2001; (2001) 41608898. [Abstract] [Full Text] |
||||
![]() |
N. J. Willmott, K. Wong, and A. J. Strong A Fundamental Role for the Nitric Oxide-G-Kinase Signaling Pathway in Mediating Intercellular Ca2+ Waves in Glia J. Neurosci., March 1, 2000; 20(5): 1767 - 1779. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zucchi, G. Yu, P. Galbani, M. Mariani, G. Ronca, and S. Ronca-Testoni Sulfhydryl Redox State Affects Susceptibility to Ischemia and Sarcoplasmic Reticulum Ca2+ Release in Rat Heart : Implications for Ischemic Preconditioning Circ. Res., November 2, 1998; 83(9): 908 - 915. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Sudo and T. E. Nelson Changes in Ryanodine-Induced Contractures by Stimulus Frequency in Malignant Hyperthermia Susceptible and Malignant Hyperthermia Nonsusceptible Dog Skeletal Muscle J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1331 - 1336. [Abstract] [Full Text] |
||||
![]() |
R. Zucchi and S. Ronca-Testoni The Sarcoplasmic Reticulum Ca2+ Channel/Ryanodine Receptor: Modulation by Endogenous Effectors, Drugs and Disease States Pharmacol. Rev., March 1, 1997; 49(1): 1 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sierralta, M. Fill, and B. A. Suarez-Isla Functionally Heterogenous Ryanodine Receptors in Avian Cerebellum J. Biol. Chem., July 19, 1996; 271(29): 17028 - 17034. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Fessenden, L. Chen, Y. Wang, C. Paolini, C. Franzini-Armstrong, P. D. Allen, and I. N. Pessah Ryanodine receptor point mutant E4032A reveals an allosteric interaction with ryanodine PNAS, February 27, 2001; 98(5): 2865 - 2870. [Abstract] [Full Text] [PDF] |
||||